Feature Channels
Neuro
Filters:
ScienceChannels:Neuro
Keywords: |
Study Shows Brain's Ability to ReorganizeScientists from the UCLA Department of Neurology have confirmed that blindness causes structural changes in the brain, indicating that the brain may reorganize itself functionally in order to adapt to a loss in sensory input. |
Released: 11/19/2009 1:15 PM EST
University of California, Los Angeles (UCLA), Health Sciences |
MedicineChannels:Neuro
Keywords: |
Good News on Multiple Sclerosis and PregnancyThere is good news for women with multiple sclerosis (MS) who are pregnant or thinking about becoming pregnant. A new study shows that pregnant women with multiple sclerosis are only slightly more likely to have cesarean deliveries and babies with a poor prenatal growth rate than women who do not have MS. |
Embargo expired: 11/18/2009 4:00 PM EST
Released: 11/12/2009 4:00 PM EST
American Academy of Neurology (AAN) |
ScienceChannels:Neuro |
BIDMC Neuroscientists Awarded Grants from The Michael J. Fox Foundation for Parkinson’s ResearchBeth Israel Deaconess Medical Center (BIDMC) neurologists Alvaro Pascual-Leone, MD, PhD, and Daniel Tarsy, MD, have been awarded grants totaling more than $1.5 million from the Michael J. Fox Foundation for Parkinson’s Research (MJFF) to conduct investigations aimed at improving the quality of life for patients with Parkinson’s disease. |
Released: 11/18/2009 2:25 PM EST
Beth Israel Deaconess Medical Center |
MedicineChannels:Neuro
Keywords: |
Cognitive Dysfunction Reversed in Mouse Model of Down's SyndromeA study by neuroscientist William C. Mobley, MD, PhD, chair of the Department of Neurosciences at the UCSD, School of Medicine, and colleagues at Stanford University Medical School has demonstrated a possible new approach to slowing the inevitable progression of cognitive decline found in Down’s syndrome. |
Embargo expired: 11/18/2009 2:00 PM EST
Released: 11/16/2009 1:10 PM EST
University of California, San Diego Health Sciences |
MedicineChannels:Neuro
Keywords: |
Neurodegenerative Disease Research Highlights from Annual Society for Neuroscience MeetingThe Web's leading source for research news on Alzheimer's and related neurodegenerative diseases reports from the world's largest annual gathering of neuroscientists. |
Released: 11/18/2009 1:05 PM EST
Alzheimer Research Forum Foundation |
MedicineChannels:Exercise and Nutrition, Neuro
Keywords: |
EMBARGOEDA reporter's PressPass is required to access this story until the embargo expires on 11/23/2009 4:00 PM EST |
11/23/2009 4:00 PM EST
Released to reporters: 11/17/2009 3:05 PM EST
|
MedicineChannels:Neuro
Keywords: |
Investigational Neurostimulation Device Aims to Reduce Stroke DamageStroke researchers at the Methodist Neurological Institute in Houston are the only ones in Texas to offer a novel device that might extend the acute stroke treatment window from three hours to 24. |
Released: 11/17/2009 9:00 AM EST
Methodist Hospital, Houston |
MedicineChannels:Neuro
Keywords: |
Smoking May Now be Considered an Established Risk Factor for ALSWhile previous studies have indicated a “probable” connection between smoking and ALS, a new study published in the Nov. 17, 2009 issue of Neurology®, the medical journal of the American Academy of Neurology, states smoking may now be considered an “established” risk factor for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease. |
Released: 11/16/2009 4:00 PM EST
Baystate Medical Center |
MedicineChannels:Aging, Neuro
Keywords: |
Analyzing Structural Brain Changes in Alzheimer’s DiseaseIn a study that promises to improve diagnosis and monitoring of Alzheimer’s disease, scientists at the University of California, San Diego have developed a fast and accurate method for quantifying subtle, sub-regional brain volume loss using magnetic resonance imaging (MRI). The study will be published the week of November 16 in the Proceedings of the National Academy of Science (PNAS). |
Released: 11/16/2009 3:00 PM EST
University of California, San Diego Health Sciences |
MedicineChannels:Neuro
Keywords: |
Researchers to Test First Gene Therapy For Alzheimer’s PatientsResearchers are preparing for the first Phase 2 clinical trial to test gene therapy treatment for Alzheimer’s disease. The study, the first multicenter neurosurgical intervention in Alzheimer’s research in the U.S., utilizes a viral-based gene transfer system, CERE-110, that makes Nerve Growth Factor (NGF), a naturally occurring protein that helps maintain nerve cell survival in the brain. |
Released: 11/16/2009 11:55 AM EST
The Mount Sinai Medical Center |

